The role of Aurora-A inhibitors in cancer therapy

Valentina Agnese(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Antonio Russo(University of Palermo)
Annals of Oncology
June 1, 2007
10.1093/annonc/mdm224
Cited by 70

Related Papers

Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
|Critical Reviews in Oncology/Hematology|2019|164
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor
|Expert Opinion on Investigational Drugs|2015|153
<i>BRAF<sup>V600E</sup></i> mutation and p27<sup>kip1</sup> expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases
|Cancer|2007|78
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond
|International Journal of Cardiology|2016|73
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines
|BioMed Research International|2013|38